Literature DB >> 55746

Letter: Growth-hormone responses in Parkinson's disease.

J D Parkes, A G Debono, C D Marsden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 55746     DOI： 10.1016/s0140-6736(76)91505-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Amphetamines, growth hormone and narcolepsy.

Authors:  J D Parkes; A G Debono; P Jenner; J Walters
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

Review 2.  Neuroendocrine markers of CNS drug effects.

Authors:  E C Johnstone; I N Ferrier
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

3.  Isolation, Characterisation and Complete Genome Sequence of a Tequatrovirus Phage, Escherichia phage KIT03, Which Simultaneously Infects Escherichia coli O157:H7 and Salmonella enterica.

Authors:  Nguyen Huan Pham-Khanh; Hirofumi Sunahara; Hanako Yamadeya; Miho Sakai; Tetsuya Nakayama; Hiromi Yamamoto; Van Truong Thi Bich; Kazuhiko Miyanaga; Kaeko Kamei
Journal:  Curr Microbiol       Date:  2019-07-24       Impact factor: 2.188

4.  Endocrine aspects of bromocriptine therapy in Parkinsonism.

Authors:  K M Shaw; A J Lees; S Franks; P Daggett; B D Thompson; G M Stern
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.